2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

ESC Clinical Practice Guidelines

27 Aug 2021

The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable. This guideline provides practical, evidence-based recommendations. The format of the previous 2016 ESC HF Guidelines was revised to make each phenotype of HF stand-alone in terms of its diagnosis and management. The therapy recommendations mention the treatment effect supported by the class and level of evidence and are presented in tables. In this guideline, we have decided to focus on the diagnosis and treatment of HF, not on its prevention.

Topic(s):

Chronic Heart Failure

Acute Heart Failure

Heart Failure

Endorsed by cardiac societies

Armenian Cardiologists Association , Austrian Society of Cardiology , Azerbaijan Society of Cardiology , Belgian Society of Cardiology , Bulgarian Society of Cardiology , Croatian Cardiac Society , Czech Society of Cardiology , Estonian Society of Cardiology , German Cardiac Society , Hungarian Society of Cardiology , Italian Federation of Cardiology , North Macedonian Society of Cardiology , Polish Cardiac Society , Portuguese Society of Cardiology , Romanian Society of Cardiology , Russian Society of Cardiology* , San Marino Society of Cardiology , Cardiology Society of Serbia , Slovak Society of Cardiology , Spanish Society of Cardiology , Tunisian Society of Cardiology and Cardiovascular Surgery , Turkish Society of Cardiology

Main resources

: Full Text and Related Materials

Full text
https://doi.org/10.1093/eurheartj/ehab368

Corrigendum [published 14 October 2021]

https://doi.org/10.1093/eurheartj/ehab670

Declaration of interest